Tuesday, February 2, 2010

Instant Neurons

A new study from Marius Wernig and colleagues at Stanford University has succeeded in transforming fibroblast cells directly into neurons. In the end, it was far simpler than expected. The identities of different cell types are known to be established during development by particular combinations of transcription factors, which, by controlling the expression of large numbers of target genes, define the genetic and biochemical profile of each cell type. It was thought that this profile of gene expression was then locked into place by chromatin proteins which bind to DNA and fix it into an active or inactive conformation. Over development, the passage from an early embryonic cell, with full potential to generate any cell type, to more differentiated cells, was believed to be unidirectional and irreversible.

The ability to clone an animal, by transferring the nucleus of a differentiated cell into a fertilised, enucleated oocyte, showed that, in fact, the profile of gene expression could be reversed, wiped clean and restored to a pristine, undifferentiated state. Groundbreaking experiments over the last few years, led by Shinya Yamanaka and colleagues, have established an even simpler method to take a differentiated somatic cell and convert it back to an undifferentiated state, a so-called induced pluripotent stem cell (iPS cell). This is achieved by forcing the expression of a set of transcription factors that define the stem cell fate – in essence, driving the biochemical profile to a stem cell pattern. Auto- and cross-regulatory interactions between these transcription factors and others in the cell ensure a stable transformation of cell identity. So, one can take a differentiated cell and reverse the direction of development, driving it back to an undifferentiated state. This is obviously a hugely powerful technique as the iPS cells can then be differentiated in vitro into many other cell types, for research or clinical purposes.

What was not clear, however, was how general this strategy might be. Was there something special about the stem cell fate or could the same approach be used to convert one differentiated cell-type directly into another, without having to go via a stem cell intermediate? Wernig and colleagues have now shown that this can be done.

They forced fibroblasts, derived from either embryonic or adult mice, to express a combination of three transcription factors which characterise a general neuronal fate, by transfecting them with lentiviruses carrying these genes. These genes, Ascl, Brn2 and Mytl1, were defined from an initial set of nineteen candidates based on genes known to be important in neuronal differentiation during development. Transfection with these genes very efficiently, over a period of several days, transformed the fibroblasts into neurons. They express neuronal proteins, show a neuronal morphology, elaborate axons and dendrites, have characteristic electrical membrane properties, fire action potentials and even synapse with each other. By all possible criteria, these are neurons. In particular, 99% of them seem to be glutamatergic and many express markers characteristic of cortical neurons.

One can expect a flurry of follow-on studies using different combinations of transcription factors to drive cells into a variety of more specific neuronal subtypes – likely to include dopaminergic neurons, motor neurons, photoreceptors and many others – as well as non-neuronal cell types.

There is every reason to expect the same approach will work with human cells, as was the case with the iPS cell technology. This will offer a rapid and very efficient method to generate a large supply of neurons from individuals with their own genotype. These are most obviously of possible use in cell replacement therapies for neurodegenerative disease, though the prospect of this in clinical practice remains some years off.

The value for clinical research is also immense, and likely more immediate. The ability to grow neurons with the genotypes of patients with psychiatric or neurological disorders, for example, offers a kind of virtual biopsy – access to neurons of the patient previously unobtainable. This will allow analysis of the possible genetic defects in each patient and their cellular consequences, likely to be invaluable in elucidating pathogenic mechanisms at a molecular level.

The future is now.

Vierbuchen, T., Ostermeier, A., Pang, Z., Kokubu, Y., Südhof, T., & Wernig, M. (2010). Direct conversion of fibroblasts to functional neurons by defined factors Nature DOI: 10.1038/nature08797


  1. Kevin, thanks for your excellent post of this important work. I'm curious as to the motile, or migrating phenotype of the transformed cells. Could the ability to regulate differentiation bi-directionally be shown to affect the difficult-to-characterize intermediate phenotypes in, say, carcinomas?

  2. Thanks Demetrios, for your comment. I do not have a very good answer to your specific question, but I certainly think that, in general, this kind of approach will be extremely useful to assay all kinds of properties, including motility and migration, of different cell types with patient-specific genotypes, across many different diseases, including cancer.

  3. Wow, that's fascinating, and an excellent post.

  4. wow I just come across to this blog, and I found this blog really interesting, really great, thank you so much for posting this, and keep posting Kevin, you are so smart.genericViagra

  5. I think that if I have your intelligence I can be the CEO of I really like your information my dear friend, thanks for sharing !

  6. These genes, Ascl, Brn2 and Mytl1, were defined from an initial set of nineteen candidates based on genes known to be important in neuronal differentiation during development.
    Generic Viagra

  7. Actually you deserve a round of applause for this extremely knowledgeable post in this section of medical transcription. Thank you for such an informative post.24 hour turnaround